Clene Enterprise Value over EBITDA from 2010 to 2024
| CLNN Stock | USD 0.34 0.01 3.03% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.89) | Current Value (0.93) | Quarterly Volatility 4.49491607 |
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene main balance sheet or income statement drivers, such as Interest Expense of 4.8 M, Tax Provision of 0.0 or Depreciation And Amortization of 1.8 M, as well as many exotic indicators such as Price To Sales Ratio of 45.21, Dividend Yield of 0.0 or PTB Ratio of 2.21. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
Clene | Enterprise Value over EBITDA |
About Clene Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Clene income statement, its balance sheet, and the statement of cash flows. Clene investors use historical funamental indicators, such as Clene's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Clene investors may use each financial statement separately, they are all related. The changes in Clene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Clene Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Clene. Please read more on our technical analysis and fundamental analysis pages.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports: Check out the analysis of Clene Correlation against competitors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Clene Stock analysis
When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Clene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.614 | Earnings Share (0.47) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0.27) | Return On Assets (0.52) |
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.